Jung; Gerard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jung; Gerard.The latest application filed is for "fusion polypeptides of human serum albumin and a therapeutically active polypeptide".

Company Profile

0.15.11

Jung; Gerard - Montlhery FR
Jung; Gerard - Montihery FR
Jung; Gerard - Leuville-sur-Orge FR
Jung, Gerard - Monlthery DE
Jung; Gerard - 91310 Montlhery FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods of treating using hormone-albumin fusion proteins Grant 7,833,521 - Fleer , et al. November 16, 2	2010-11-16
Fusion Polypeptides of Human Serum Albumin and a Therapeutically Active Polypeptide App 20090176276 - Fleer; Reinhard ; et al.	2009-07-09
Methods of treatment with interferson and albumin fusion protein Grant 7,435,410 - Fleer , et al. October 14, 2	2008-10-14
Fusion polypeptides of human serum albumin and a therapeutically active polypeptide Grant 7,410,779 - Fleer , et al. August 12, 2	2008-08-12
Insulin and albumin fusion protein Grant 7,094,577 - Fleer , et al. August 22, 2	2006-08-22
Interleukin and albumin fusion protein Grant 7,081,354 - Fleer , et al. July 25, 2	2006-07-25
Hormone and albumin fusion protein Grant 7,056,701 - Fleer , et al. June 6, 2	2006-06-06
Fusion polypeptides of human serum albumin and a therapeutically active polypeptide App 20060105429 - Fleer; Reinhard ; et al.	2006-05-18
G-CSF and albumin fusion protein Grant 7,041,478 - Fleer , et al. May 9, 2	2006-05-09
Methods of treatment with erythropoietin and albumin fusion protein Grant 6,989,365 - Fleer , et al. January 24, 2	2006-01-24
Erythropoietin and albumin fusion protein, nucleic acids, and methods thereof Grant 6,987,006 - Fleer , et al. January 17, 2	2006-01-17
Interferon and albumin fusion protein Grant 6,972,322 - Fleer , et al. December 6, 2	2005-12-06
Fusion polypeptides of human serum albumin and a therapeutically active polypeptide App 20050239167 - Fleer, Reinhard ; et al.	2005-10-27
Fusion polypeptides of human serum albumin and a therapeutically active polypeptide App 20040086977 - Fleer, Reinhard ; et al.	2004-05-06
Fusion polypeptides of human serum albumin and a therapeutically active polypeptide App 20040086976 - Fleer, Reinhard ; et al.	2004-05-06
Fusion polypeptides of human serum albumin and a therapeutically active polypeptide Grant 6,686,179 - Fleer , et al. February 3, 2	2004-02-03
Fusion polypeptides of human serum albumin and a therapeutically active polypeptide App 20030082747 - Fleer, Reinhard ; et al.	2003-05-01
Fusion polypeptides of human serum albumin and a therapeutically active polypeptide App 20030036170 - Fleer, Reinhard ; et al.	2003-02-20
Fusion polypeptides of human serum albumin and a therapeutically active polypeptide App 20030036172 - Fleer, Reinhard ; et al.	2003-02-20
Fusion polypeptides of human serum albumin and a therapeutically active polypeptide App 20030036171 - Fleer, Reinhard ; et al.	2003-02-20
Fusion polypeptides of human serum albumin and a therapeutically active polypeptide App 20030022308 - Fleer, Reinhard ; et al.	2003-01-30
Fusion polypeptides of human serum albumin and a therapeutically active polypeptide App 20020151011 - Fleer, Reinhard ; et al.	2002-10-17
Fusion polypeptides comprising human serum albumin, nucleic acids encoding same, and recombinant expression thereof Grant 5,876,969 - Fleer , et al. March 2, 1	1999-03-02
Process for inclusion of mycorrhizae and actinorhizae in a matrix Grant 5,021,350 - Jung , et al. June 4, 1	1991-06-04
Low-water-activity inocula for biological control Grant 4,886,664 - Jung , et al. December 12, 1	1989-12-12
Means for embedding microorganisms in a polymer matrix Grant 4,434,231 - Jung February 28, 1	1984-02-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.